Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
2013 · Nature Medicine · 753 citations
https://doi.org/10.1038/nm.3089
J
Jeong Heo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
363
Papers
10.1K
Citations
47
h-index
139
i10-index
Jeong Heo is an academic researcher from Palo Alto University. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 47, co-authored 309 publications.
ORCID: 0000-0003-0961-7851Papers by this author
worksAtezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 415 citations
https://doi.org/10.1016/s0140-6736(23)01796-8
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 415 citations
https://doi.org/10.1016/s0140-6736(23)01796-8
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 415 citations
https://doi.org/10.1016/s0140-6736(23)01796-8
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2013 · Cancer Research · 250 citations
https://doi.org/10.1158/0008-5472.can-12-2687
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
2025 · The Lancet · 170 citations
https://doi.org/10.1016/s0140-6736(24)02551-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat